Pharmacokinetics Study for Hyperprolactinemia Among Schizophrenics Switched From Risperidone to Risperidone Long-Acting Injection
Authors:
- Ya Mei BaiYBYa Mei Bai
- Tzu Ting ChenTCTzu Ting Chen
- Wen Kuo LinWLWen Kuo Lin
- Wen-Ho ChangWCWen-Ho Chang
- Bojian WuBWBojian Wu
- Chih Hung HungCHChih Hung Hung
- Pesus ChouPCPesus Chou
- Jen-Yeu ChenJCJen-Yeu Chen
- 1 June 2007
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 27 (3) , 306-308
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin LevelsAmerican Journal of Psychiatry, 2005
- Pharmacokinetics and tolerability of long-acting risperidone in schizophreniaSchizophrenia Research, 2004
- Prolaktinplasmaspiegel und Häufigkeit der endokrinologischen Begleitwirkungen unter Therapie mit den atypischen NeuroleptikaPsychiatrische Praxis, 2003
- Elevation of Prolactin Levels by Atypical AntipsychoticsAmerican Journal of Psychiatry, 2002
- Increased Dopamine D2 Receptor Occupancy and Elevated Prolactin Level Associated With Addition of Haloperidol to ClozapineAmerican Journal of Psychiatry, 2001
- Risperidone in Acutely Exacerbated SchizophreniaThe Journal of Clinical Psychiatry, 2000
- Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of ratPsychopharmacology, 1998
- The Pharmacokinetic Properties of Topical LevocabastineClinical Pharmacokinetics, 1995
- Plasma protein binding of risperidone and its distribution in bloodPsychopharmacology, 1994
- Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.The Journal of Pharmacology and Experimental Therapeutics, 1992